Niterra Ventures Participates in Oversubscribed $50M Growth Financing Round for Cala
Funding will accelerate commercialization of innovative, FDA-cleared wearable treatments for managing essential tremors SANTA CLARA, Calif.–(BUSINESS WIRE)–Niterra Ventures today announced its participation in the oversubscribed $50M funding round for Cala, the bioelectronic medicine leader. Recognized by Fast Company’s…